Yongcan Wu

Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach

Yilan Wang, Zherui Shen, Sijing Zhao et al. · Ecotoxicology and Environmental Safety · 2022 · 71 citations · Full text

Veterinary Medicine, Pharmacology, Toxicology +17

Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro

Caixia Pei, Fei Wang, Demei Huang et al. · Journal of Inflammation Research · 2021 · 64 citations · Full text

Life Sciences, Pharmacology, Toxicology +17

Astragaloside IV pre-treatment attenuates PM2.5-induced lung injury in rats: Impact on autophagy, apoptosis and inflammation

Zhenxing Wang, Yongcan Wu, Caixia Pei et al. · Phytomedicine · 2021 · 53 citations

Life Sciences, Cell Biology, Pharmacology +10

Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats

Yongcan Wu, Demei Huang, Xiaomin Wang et al. · International Immunopharmacology · 2021 · 51 citations

Life Sciences, Immunology, Pathology +17

Astragaloside IV alleviates PM2.5-induced lung injury in rats by modulating TLR4/MyD88/NF-κB signalling pathway

Yongcan Wu, Wei Xiao, Caixia Pei et al. · International Immunopharmacology · 2020 · 49 citations

Life Sciences, Immunology, Pharmacology +14